Drug: AZATHIOPRINE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
77935943 | AZATHIOPRINE. | Foetal exposure during pregnancy | MYLAN | 0.00 | 0 | 20160921 | GB | |
97959143 | AZATHIOPRINE. | Foetal exposure during pregnancy | JANSSEN | 0.00 | F | 0 | 20160708 | NL |
97959153 | AZATHIOPRINE. | Foetal exposure during pregnancy | JANSSEN | 0.00 | M | 0 | 20160706 | NL |
117054073 | AZATHIOPRINE. | Foetal exposure during pregnancy | SANDOZ | 4.00 MON | F | 3 KG | 20160712 | GB |
122544652 | AZATHIOPRINE. | Foetal exposure during pregnancy | MYLAN | 0.00 | 0 | 20160808 | GB | |
126269281 | AZATHIOPRINE. | Foetal exposure during pregnancy | MYLAN | 0.00 | 0 | 20160805 | PT | |
127781781 | AZATHIOPRINE. | Foetal exposure during pregnancy | SANDOZ | 0.00 | 0 | 20160925 | IT | |
127834041 | AZATHIOPRINE. | Foetal exposure during pregnancy | BAYER | 0.00 | 2 KG | 20160927 | IT |
Total Records: 8 Number of Pages: 1